Form 8-K - Current report:
SEC Accession No. 0001792044-22-000015
Filing Date
2022-05-09
Accepted
2022-05-09 08:15:09
Documents
14
Period of Report
2022-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vtrs-20220509.htm   iXBRL 8-K 34187
2 EX-99.1 exhibit991-1q22earningsrel.htm EX-99.1 363342
6 picture1.jpg GRAPHIC 4362
  Complete submission text file 0001792044-22-000015.txt   569685

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtrs-20220509.xsd EX-101.SCH 1918
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtrs-20220509_lab.xml EX-101.LAB 24229
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtrs-20220509_pre.xml EX-101.PRE 12610
8 EXTRACTED XBRL INSTANCE DOCUMENT vtrs-20220509_htm.xml XML 10572
Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317 (724) 514-1465
Viatris Inc (Filer) CIK: 0001792044 (see all company filings)

EIN.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39695 | Film No.: 22903330
SIC: 2834 Pharmaceutical Preparations